Login / Signup

[The immunocytokine FAP-IL2v : a potent co-therapy for preventing resistance to trastuzumab in HER2 + breast cancer].

Eléonore PariselLaura PrudhommeJonathan Pol
Published in: Medecine sciences : M/S (2024)
Keyphrases
  • epidermal growth factor receptor
  • metastatic breast cancer
  • anti inflammatory
  • breast cancer risk